Cargando…
Zerumbone Modulates α(2A)-Adrenergic, TRPV1, and NMDA NR2B Receptors Plasticity in CCI-Induced Neuropathic Pain In Vivo and LPS-Induced SH-SY5Y Neuroblastoma In Vitro Models
Zerumbone has shown great potential in various pathophysiological models of diseases, particularly in neuropathic pain conditions. Further understanding the mechanisms of action is important to develop zerumbone as a potential anti-nociceptive agent. Numerous receptors and pathways function to inhib...
Autores principales: | Chia, Jasmine Siew Min, Izham, Noor Aishah Mohammed, Farouk, Ahmad Akira Omar, Sulaiman, Mohd Roslan, Mustafa, Sanam, Hutchinson, Mark R., Perimal, Enoch Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064019/ https://www.ncbi.nlm.nih.gov/pubmed/32194397 http://dx.doi.org/10.3389/fphar.2020.00092 |
Ejemplares similares
-
Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model
por: Kaswan, Nur Khalisah, et al.
Publicado: (2021) -
Effect of zerumbone on scopolamine-induced memory impairment and anxiety-like behaviours in rats
por: Jafarian, Sahba, et al.
Publicado: (2019) -
Zerumbone-Induced Analgesia Modulated via Potassium Channels and Opioid Receptors in Chronic Constriction Injury-Induced Neuropathic Pain
por: Gopalsamy, Banulata, et al.
Publicado: (2020) -
Antiallodynic and antihyperalgesic activities of zerumbone via the suppression of IL-1β, IL-6, and TNF-α in a mouse model of neuropathic pain
por: Gopalsamy, Banulata, et al.
Publicado: (2017) -
Zerumbone Ameliorates Neuropathic Pain Symptoms via Cannabinoid and PPAR Receptors Using In Vivo and In Silico Models
por: Chia, Jasmine Siew Min, et al.
Publicado: (2021)